PL EN


Preferences help
enabled [disable] Abstract
Number of results
Journal
2012 | 10 | 1 | 121-126
Article title

Development and validation of the stability-indicating LC-UV method for the determination of cefoselis sulphate

Content
Title variants
Languages of publication
EN
Abstracts
EN
The stability-indicating LC assay method was developed and validated for quantitative determination of cefoselis sulphate in the presence of degradation products formed during the forced degradation studies. An isocratic, RP-HPLC method was developed with C-18 (250 × 4.6 mm, 5 µm) column and 12 mM ammonium acetate-acetonitrile (95:5 V/V) as a mobile phase. The flow rate of the mobile phase was 1.0 mL min−1. Detection wavelength was 260 nm and temperature was 30°C. Cefoselis similarly to other cephalosporins was subjected to stress conditions of degradation in aqueous solutions including hydrolysis, oxidation, photolysis and thermal degradation. The developed method was validated with regard to linearity, accuracy, precision, selectivity and robustness. The method was applied successfully for identification and determination of cefoselis sulphate in pharmaceuticals and during kinetic studies.
Publisher
Journal
Year
Volume
10
Issue
1
Pages
121-126
Physical description
Dates
published
1 - 2 - 2012
online
24 - 11 - 2011
References
  • [1] T. Kuriyama, T. Karasawa, K. Nakagawa, S. Nakamura, E. Yamamoto, Oral Microbiol. Immunol. 17, 285 (2002) http://dx.doi.org/10.1034/j.1399-302X.2002.170504.x[Crossref]
  • [2] M.W. Climo, S.M. Markowitz, D.S. Williams, C.G. Hale-Cooper, G.L. Archer, J. Antimicrob. Chemother. 40, 59 (1997) http://dx.doi.org/10.1093/jac/40.1.59[Crossref]
  • [3] H.C. Neu, N.X. Chin, H.B. Huang, Antimicrob Agents Chemother 37(3), 566 (1993) [Crossref]
  • [4] G. Patel, S. Rajput, Acta Chromatogr. 23(2), 215 (2011) http://dx.doi.org/10.1556/AChrom.23.2011.2.3[Crossref]
  • [5] Y. Ikeda, J. Ban, T. Ishikawa, S. Hashiguchi, S. Urayama, H. Horibe, Chem. Pharm. Bull. 56(10), 1406 (2008) http://dx.doi.org/10.1248/cpb.56.1406[Crossref]
  • [6] A. Jelińska, L. Dobrowolski, I. Oszczapowicz, J. Pharm. Biomed. Anal. 35(5), 1273 (2004) http://dx.doi.org/10.1016/j.jpba.2004.03.017[Crossref]
  • [7] T. Sugioka, T. Asano, Y. Chikaraishi, E. Suzuki, A. Sano, T. Kuriki, M. Shirotsuka, K. Saito, Chem. Pharm. Bull. 38(7), 1998 (1990) http://dx.doi.org/10.1248/cpb.38.1998[Crossref]
  • [8] J.O. Fubara, R.E. Notari, J. Pharm. Sci. 87(12), 1572 (1998) http://dx.doi.org/10.1021/js980170y[Crossref]
  • [9] B. Medenecka, A. Jelińska, M. Zając, M. Bałdyka, K. Juszkiewicz, I. Oszczapowicz, Acta Pol. Pharm. 66(5), 563 (2009) [PubMed]
  • [10] A. Jelińska, B. Medenecka, M. Zając, M. Knajsiak, Acta Pol. Pharm. 65(2), 261 (2008) [PubMed]
  • [11] M. Zając, A. Jelińska, P. Zalewski, Acta Pol. Pharm. 62(2), 89 (2005) [PubMed]
  • [12] A. Jelińska, I. Dudzińska, M. Zając, I. Oszczapowicz, W. Krzewski Acta Pol. Pharm. 62(3)183 (2005) [PubMed]
  • [13] M. Zając, A. Jelińska, L. Dobrowolski, I. Oszczapowicz, J. Pharm. Biomed. Anal. 32(6), 1181 (2003) http://dx.doi.org/10.1016/S0731-7085(03)00237-1[Crossref]
  • [14] A. Jelińska, M. Zając, J. Gostomska, M. Szczepaniak, Farmaco 58(4), 309 (2003) http://dx.doi.org/10.1016/S0014-827X(02)00023-X[Crossref]
  • [15] A. Jelińska, M. Zając, M. Jakubowska, React. Kinet. Catal. Lett. 73(2), 325 (2001) http://dx.doi.org/10.1023/A:1014175710690[Crossref]
  • [16] J. Cielecka-Piontek, K. Michalska, P. Zalewski, A. Jelińska, Curr. Pharm. Anal. 7(4), 213 (2011)
  • [17] K. Ohtaki, K. Matsubara, S. Fujimaru, K. Shimizu, T. Awaya, M. Suno, K. Chiba, N. Hayase, H. Shiono, J. Neural. Transm. 111, 1523 (2004) http://dx.doi.org/10.1007/s00702-004-0177-0[Crossref]
  • [18] H. Ueo, H. Motohashi, T. Katsura, K. Inui, Biochemical Pharmacology 70, 1104 (2005) http://dx.doi.org/10.1016/j.bcp.2005.06.024[Crossref]
  • [19] M. Nagata, M. Yasuhara, Biol. Pharm. Bull. 24(9), 1049 (2001) http://dx.doi.org/10.1248/bpb.24.1049[Crossref]
  • [20] ICH Q2B, Validation of Analytical Procedures, Methodology, International Conference on Harmonization (IFPMA, Geneva, 2000)
  • [21] M. Bakshi, B. Singh, A. Singh, S. Singh, J. Pharm. Biomed. Anal. 26, 891 (2001) http://dx.doi.org/10.1016/S0731-7085(01)00475-7[Crossref]
  • [22] M. Bakhi, S. Singh, J. Pharm. Biomed. Anal. 28, 1011 (2002) http://dx.doi.org/10.1016/S0731-7085(02)00047-X[Crossref]
  • [23] R. Sehrawat, M. Maithani, R. Singh, Chromatographia 72, 1 (2010) http://dx.doi.org/10.1365/s10337-010-1612-z[Crossref]
Document Type
Publication order reference
YADDA identifier
bwmeta1.element.-psjd-doi-10_2478_s11532-011-0112-9
Identifiers
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.